Sumitomo Chemical is a leading provider of gRNAs for therapeutic genome editing, recognized for strong reputation in reliability and quality excellence.

Our core strengths include exceptional product purity, advanced analytical capabilities, and expedited lead times for GMP production.

At our brand-new, state-of-the-art cGMP facility in Japan, we manufacture high-purity gRNA ranging from 80 to 140 nucleotides, with ongoing development efforts to extend beyond this range. Recently, we have successfully produced 200mer gRNA at lab scale by linear solid-phase synthesis. Our platform ensures unmatched quality: 100mer gRNA at 90% purity, 130mer at over 80% purity. Additionally, we offer the flexibility to incorporate various types and numbers of modifications to longmers. Our robust and standardized manufacturing method enables seamless transitions and scalability from research to clinical development, and ultimately to commercial production.

Sumitomo Chemical is fully attuned to the growing demand for high-purity oligonucleotides, even for early-phase clinical trials. If you are looking for a reliable partner for GMP-grade gRNA production.